APRE · Aprea Therapeutics, Inc.
$0.64
+0.03 (+4.25%)
At close · Jul 29
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have identified conditions and events that raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 13, 2026
Market Cap
$7.60M
Shares
12.38M
No listed options were found for APRE.